Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

Hobson, D., Curry, R. L., Beare, A. S., & Ward-Gardner, A. (1972) · Epidemiology and Infection · doi:10.1017/s0022172400022610 · Cited by 1,003 · see citing works

Properties of mouse and human IgG receptors and their contribution to disease models

Bruhns, P. (2012) · Blood · doi:10.1182/blood-2012-01-380121 · Cited by 869 · see citing works

Highly Conserved Protective Epitopes on Influenza B Viruses

Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 867 · see citing works

A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M. A. C., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 823 · see citing works

Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749 · see citing works

Mouse and human FcR effector functions

Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 573 · see citing works

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983

Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P., & Nerome, K. (1990) · Virology · doi:10.1016/0042-6822(90)90186-u · Cited by 539 · see citing works

A New Type of Virus from Epidemic Influenza

Francis, T. (1940) · Science · doi:10.1126/science.92.2392.405 · Cited by 274 · see citing works

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

Henry Dunand, C. J., Leon, P. E., Huang, M., Choi, A., Chromikova, V., Ho, I. Y., Tan, G. S., Cruz, J., Hirsh, A., Zheng, N.-Y., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.014 · Cited by 268 · see citing works

The influenza virus hemagglutinin head evolves faster than the stalk domain

Roubidoux, E. K., Qiu, X., Wilson, P. C., Bahl, J., & Krammer, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-28706-1 · Cited by 231 · see citing works

Influenza B virus evolution: Co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses

Yamashita, M., Krystal, M., Fitch, W. M., & Palese, P. (1988) · Virology · doi:10.1016/0042-6822(88)90238-3 · Cited by 223 · see citing works

Specific Residues of the Influenza A Virus Hemagglutinin Viral RNA Are Important for Efficient Packaging into Budding Virions

Marsh, G. A., Hatami, R., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01144-07 · Cited by 203 · see citing works

Universal influenza virus vaccines and therapeutic antibodies

Nachbagauer, R., & Krammer, F. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.02.009 · Cited by 184 · see citing works

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

He, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 180 · see citing works

A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates

Krammer, F., Margine, I., Tan, G. S., Pica, N., Krause, J. C., & Palese, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043603 · Cited by 174 · see citing works

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

Margine, I., Palese, P., & Krammer, F. (2013) · Journal of Visualized Experiments · doi:10.3791/51112 · Cited by 169 · see citing works

In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen

Wohlbold, T. J., & Krammer, F. (2014) · Viruses · doi:10.3390/v6062465 · Cited by 168 · see citing works

Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization

Brandenburg, B., Koudstaal, W., Goudsmit, J., Klaren, V., Tang, C., Bujny, M. V., Korse, H. J. W. M., Kwaks, T., Otterstrom, J., Juraszek, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080034 · Cited by 166 · see citing works

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

He, W., Chen, C.-J., Mullarkey, C. E., Hamilton, J. R., Wong, C. K., Leon, P. E., Uccellini, M. B., Chromikova, V., Henry, C., Hoffman, K. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00928-3 · Cited by 166 · see citing works

Broadly neutralizing antibodies against influenza virus and prospects for universal therapies

Ekiert, D. C., & Wilson, I. A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.005 · Cited by 150 · see citing works

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

Tan, G. S., Leon, P. E., Albrecht, R. A., Margine, I., Hirsh, A., Bahl, J., & Krammer, F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005578 · Cited by 147 · see citing works

Trichoplusia ni cells (High FiveTM) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

Krammer, F., Schinko, T., Palmberger, D., Tauer, C., Messner, P., & Grabherr, R. M. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9268-3 · Cited by 131 · see citing works

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes

Wohlbold, T. J., Podolsky, K. A., Chromikova, V., Roubidoux, E. K., Falconieri, V., Meade, P. S., Amanat, F., Tan, J., tenOever, B. R., Tan, G. S., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0011-8 · Cited by 130 · see citing works

Influenza B Virus NS1-Truncated Mutants: Live-Attenuated Vaccine Approach

Hai, R., Martínez‐Sobrido, L., Fraser, K. A., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01213-08 · Cited by 126 · see citing works

Characterization of a Broadly Neutralizing Monoclonal Antibody That Targets the Fusion Domain of Group 2 Influenza A Virus Hemagglutinin

Tan, G. S., Lee, P. S., Hoffman, R. M. B., Mazel‐Sanchez, B., Krammer, F., Leon, P. E., Ward, A. B., Wilson, I. A., & Palese, P. (2014) · Journal of Virology · doi:10.1128/jvi.02289-14 · Cited by 119 · see citing works

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

Leon, P. E., He, W., Mullarkey, C. E., Bailey, M. J., Miller, M. S., Krammer, F., Palese, P., & Tan, G. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613225113 · Cited by 118 · see citing works

Influenza B Viruses: Not to be Discounted

van de Sandt, C. E., Bodewes, R., Rimmelzwaan, G. F., & de Vries, R. D. (2015) · Future Microbiology · doi:10.2217/fmb.15.65 · Cited by 104 · see citing works

Structural insights into the design of novel anti-influenza therapies

Wu, N. C., & Wilson, I. A. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0025-9 · Cited by 96 · see citing works

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses

Shen, C., Chen, J., Li, R., Zhang, M., Wang, G., Stegalkina, S. S., Zhang, L., Chen, J., Cao, J., Bi, X., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam5752 · Cited by 93 · see citing works

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

Ermler, M. E., Roubidoux, E. K., Sun, W., Hai, R., Amanat, F., Chromikova, V., Palese, P., & Krammer, F. (2017) · Journal of Virology · doi:10.1128/jvi.00286-17 · Cited by 90 · see citing works

Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice

Wohlbold, T. J., Chromikova, V., Tan, G. S., Meade, P. S., Amanat, F., Comella, P., Hirsh, A., & Krammer, F. (2015) · Journal of Virology · doi:10.1128/jvi.02275-15 · Cited by 81 · see citing works

Structural basis for the divergent evolution of influenza B virus hemagglutinin

Ni, F., Kondrashkina, E., & Wang, Q. (2013) · Virology · doi:10.1016/j.virol.2013.07.035 · Cited by 67 · see citing works

A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

Chai, N., Swem, L. R., Park, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14234 · Cited by 67 · see citing works

HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids

Cox, F., Kwaks, T., Brandenburg, B., Koldijk, M. H., Klaren, V., Smal, B., Korse, H. J. W. M., Geelen, E., Tettero, L., Zuijdgeest, D., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00399 · Cited by 57 · see citing works

Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge

Krammer, F., Albrecht, R. A., Tan, G. S., Margine, I., Hai, R., Schmolke, M., Runstadler, J. A., Andrews, S. F., Wilson, P. C., Cox, R. J., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03095-13 · Cited by 54 · see citing works

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

Margine, I., Palese, P., & Krammer, F. (2013) · Journal of Visualized Experiments · doi:10.3791/51112-v · Cited by 54 · see citing works

Influenza-associated pediatric deaths--United States, September 2010-August 2011.

(2011) · PubMed · Cited by 51 · see citing works

Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus?

Tan, J., Arunkumar, G. A., & Krammer, F. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.002 · Cited by 43 · see citing works

The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses

Thulin, N. K., & Wang, T. T. (2018) · Vaccines · doi:10.3390/vaccines6030036 · Cited by 37 · see citing works

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations

Rajendran, M., Sun, W., Comella, P., Nachbagauer, R., Wohlbold, T. J., Amanat, F., Roubidoux, E. K., Palese, P., & Krammer, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194830 · Cited by 31 · see citing works

The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine

Jegaskanda, S. (2018) · Vaccines · doi:10.3390/vaccines6020027 · Cited by 24 · see citing works

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses

Vigil, A., Estellés, A., Kauvar, L. M., Johnson, S. K., Tripp, R. A., & Wittekind, M. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02269-17 · Cited by 19 · see citing works

Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation

White, K. M., Ayllón, J., Mena, I., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.050 · Cited by 10 · see citing works

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Amanat, F., Thapa, M., Lei, T., Ahmed, S. M. S., Adelsberg, D. C., Carreño, J. M., Strohmeier, S., Schmitz, A. J., Zafar, S., Zhou, J. Q., et al. (2021) · Cell · doi:10.1016/j.cell.2021.06.005 · Cited by 273 · see citing works

The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin

Щербинин, Д. Н., Alekseeva, S. V., Шмаров, М. М., Smirnov, Y. A., Naroditskiy, B. S., & Al, G. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-1-13-20 · Cited by 7 · see citing works

[Importance of cross-reacting antibodies in creating resistance to influenza].

Al, P. (1982) · PubMed

Minor Changes in the Hemagglutinin of Influenza A(H1N1)2009 Virus Alter Its Antigenic Properties

Strengell, M., Ikonen, N., Ziegler, T. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025848 · Cited by 69 · see citing works

Identification and analysis of B cell epitopes of hemagglutinin of H1N1 influenza virusPreprint

Feng, Q., Huang, X., Feng, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1673189/v1

Reconstructed H3N2 influenza virus predicted from influenza vaccine strains improved cross-protective immunity in mice

Fangye, Z., Jinshui, L., Hongwei, N., Jing, T., Yupeng, X., & Qinqin, C. (2016) · African Journal of Microbiology Research · doi:10.5897/ajmr2016.8021